The beta-2-glycoprotein I and antiphospholipid antibodies

Y. Shoenfeld, P. L. Meroni

Research output: Contribution to journalArticlepeer-review


Beta2-GPI is a single chain, 50 kd glycoprotein made up of 326 amino-acids, present in human plasma at concentrations of about 200 μg/ml. It has been shown to represent the 'serum cofactor' important in determining the binding of aCL to phospholipids both in fluid and in solid phase assays. Its cofactor activity is demonstrable for aPL antibodies from patients with autoimmune but not with infectious diseases. It is immunogenic in heterospecific models, and immunization with β2-GPI seems to be able to induce the production not only of anti-β2-GPI but also of aPL antibodies. Most probably its binding to GL changes the configuration of phospholipids to a more immunogenic one. The various characteristics of β1-GPI are summarized in Table I.β2-GPI has been recognized as a natural anticoagulant protein, but its possible role in the pathogenesis of the APLS remains to be determined.

Original languageEnglish
Pages (from-to)205-209
Number of pages5
JournalClinical and Experimental Rheumatology
Issue number2
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Immunology
  • Rheumatology


Dive into the research topics of 'The beta-2-glycoprotein I and antiphospholipid antibodies'. Together they form a unique fingerprint.

Cite this